Results 251 to 260 of about 1,271,973 (317)

Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling

open access: yesFEBS Open Bio, EarlyView.
Pharmacological inhibition of PERK in a DEN‐induced mouse model of liver cancer does not reduce tumor burden but alters cellular stress signaling. Despite blocking PERK activity, downstream stress responses, including CHOP expression, remain active, suggesting compensatory mechanisms within the unfolded protein response that may influence tumor ...
Ada Lerma‐Clavero   +5 more
wiley   +1 more source

One size does not fit all: An in vitro evaluation of the effects of bezafibrate and medroxyprogesterone acetate on human SH‐SY5Y and U‐87 MG cancer cells

open access: yesFEBS Open Bio, EarlyView.
Drugs previously repurposed to target blood cancers reduced neuroblastoma and glioblastoma cell growth and viability. However, their levels of anticancer activity were different and their clinical application may be problematic due to side effects at effective doses.
Abhishek Kharawatkar   +4 more
wiley   +1 more source

The predictive value of preoperative clinical laboratory indicators combined with sarcopenia for postoperative complications of gastric cancer. [PDF]

open access: yesFront Med (Lausanne)
Bai S   +13 more
europepmc   +1 more source

Renal outcomes and predictive value of dyslipidemia in patients with IgA nephropathy: a retrospective cohort study. [PDF]

open access: yesFront Med (Lausanne)
Ruan Y   +9 more
europepmc   +1 more source

The Predictive Value of the Tumor-Stroma Ratio for Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer. [PDF]

open access: yesInt J Cancer
Andour L   +8 more
europepmc   +1 more source

Limited predictive value of Padua and Caprini scores for venous thromboembolism in AECOPD patients with atrial fibrillation. [PDF]

open access: yesSci Rep
Pu J   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy